XWXiang Wang

Xiang Wang

*This is an algorithmically generated author record based on publicly available information.

Xiang Wang has a total of 1 co-authors. Here are the top co-authors by number of shared publications:

  • Chunxue Gao

    Minimally Invasive Cosmetic Surgery Department, Sichuan Yuehao Medical Aesthetics Hospital Chengdu 610036, Sichuan, China

    1 shared publication

Latest Publications

  • Polycaprolactone versus calcium hydroxylapatite injectable treatments in the T-zone for facial rejuvenation: a clinical comparative study

    by Chunxue Gao, Xiang Wang

    Objective: This analysis, being a retrospective study, set out to compare the effect of polycaprolactone (PCL) versus calcium hydroxylapatite (CaHA) in injectable T-zone rejuvenation. Methods: A total of 147 patients receiving facial T-zone rejuvenation with injectables at our center constituted the research cohort. Inter-group assessments (PCL group with 72 cases vs. CaHA group with 75 cases) were conducted from the dimensions of curative efficacy, dynamic nasion displacement, physician-assessed tactile perception of hardness score, nasofrontal angle, effect maintenance duration, treatment interval, facial skin laxity status, facial aesthetic score, serum growth factors, and patient satisfaction. Results: As compared to the PCL group, the CaHA group (1) showed an evidently higher excellent-and-good rate and superior patient satisfaction; (2) demonstrated lower dynamic nasion displacement, nasofrontal angle, and facial skin laxity-associated indices (except the interzygomatic distance) post-operation; (3) exhibited statistically higher post-treatment physician-assessed tactile perception of hardness scores, nasofrontal angle target achievement rate, longer effect maintenance duration, better maintenance of the radix height and chin projection at 12 months, extended treatment intervals, as well as higher aesthetic scores and VEGF and bFGF levels. No significant inter-group difference in the total adverse reactions was identified. Conclusion: CaHA is clinically advantageous over PCL in injectable T-zone rejuvenation.